Drug Shortage Report for XYLOCAINE JELLY 2%
Report ID | 186439 |
Drug Identification Number | 00001694 |
Brand name | XYLOCAINE JELLY 2% |
Common or Proper name | lidocaine HCI 2% Jelly 30mL Aluminum Tube |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | GEL |
Route of administration | TOPICAL TOPICAL |
Packaging size | 1 Tube |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-11-01 |
Actual start date | |
Estimated end date | 2023-12-31 |
Actual end date | 2023-05-01 |
Shortage status | Avoided shortage |
Updated date | 2023-05-01 |
Company comments | VR44900CA1 XYLOCAINE 20MG/G GEL TB 1X30G ASP |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-05-01 | French | Compare |
v3 | 2023-05-01 | English | Compare |
v2 | 2023-03-07 | French | Compare |
v1 | 2023-03-07 | English | Compare |
Showing 1 to 4 of 4